Wolverine Trading
INO icon

Wolverine Trading’s Inovio Pharmaceuticals INO Stock Holding History

Wolverine Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,500
Closed -$26.4K – 5872
2025
Q2 		$26.4K Buy
+12,500
New +$24K ﹤0.01% 4444
2025
Q1 		– Sell
-20,600
Closed -$36.7K – 5245
2024
Q4 		$36.7K Buy
20,600
+7,000
+51% +$31K ﹤0.01% 5038
2024
Q3 		$79.7K Sell
13,600
-6,200
-31% -$51.1K ﹤0.01% 4415
2024
Q2 		$160K Buy
+19,800
New +$208K ﹤0.01% 3924
2024
Q1 		– Sell
-1,383
Closed -$8.47K – 4851
2023
Q4 		$8.47K Sell
1,383
-684
-33% -$3.38K ﹤0.01% 4408
2023
Q3 		$9.65K Buy
2,067
+9
+0.4% +$50 ﹤0.01% 4368
2023
Q2 		$11.6K Buy
+2,058
New +$16.6K ﹤0.01% 4134
2023
Q1 		– Sell
-11,008
Closed -$206K – 4566
2022
Q4 		$206K Buy
11,008
+3,850
+54% +$87.3K ﹤0.01% 3114
2022
Q3 		$144K Sell
7,158
-1,067
-13% -$27.3K ﹤0.01% 3769
2022
Q2 		$177K Buy
8,225
+242
+3% +$6.82K ﹤0.01% 3613
2022
Q1 		$350K Sell
7,983
-7,842
-50% -$353K ﹤0.01% 3696
2021
Q4 		$986K Buy
+15,825
New +$1.27M ﹤0.01% 2638
2021
Q3 		– Sell
-12,017
Closed -$1.36M – 6570
2021
Q2 		$1.36M Buy
12,017
+450
+4% +$43.2K ﹤0.01% 2428
2021
Q1 		$1.22M Sell
11,567
-9,366
-45% -$1.23M ﹤0.01% 2491
2020
Q4 		$2.26M Buy
+20,933
New +$2.79M ﹤0.01% 1595
2020
Q3 		– Sell
-18,467
Closed -$7.02M – 4832
2020
Q2 		$7.02M Buy
+18,467
New +$2.97M 0.02% 634

Other funds holding INO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's INO Position: Q4 2024 in Review

Wolverine Trading sold out of Inovio Pharmaceuticals (INO) in Q4 2024, closing a stake of 12,161 shares — an estimated $53.8K sold.

Wolverine Trading first reported a position in INO in Q2 2020 and held it in 8 quarters. The position peaked at $469K in Q2 2020. 104 funds tracked by Wall St. Rank hold INO as of Q4 2024.

  • Wolverine Trading reported no remaining Inovio Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 12,161 Inovio Pharmaceuticals shares in Q4 2024, an estimated $53.8K.
  • Wolverine Trading first reported a position in Inovio Pharmaceuticals in Q2 2020 and held it in 8 quarters.
  • Wolverine Trading's Inovio Pharmaceuticals position peaked at $469K in Q2 2020.
  • 104 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.